# Hercules Capital, Inc.: overview

HTGC · NYSE · CIK 1280784 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/htgc.md) · [Financials](/companies/htgc/financials.md) · [Filings](/companies/htgc/filings.md) · [Insiders](/companies/htgc/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | [0.29](/filings/0001280784-26-000027.md) | [0.43](/filings/0001280784-26-000042.md) | [0.63](/filings/0001280784-26-000054.md) | not reported | [0.23](/filings/0001280784-26-000027.md) | [0.67](/filings/0001280784-26-000042.md) | [0.48](/filings/0001280784-26-000054.md) |
| Free cash flow | $m | [(29.2) d](/filings/0001280784-26-000009.md) | [(222)](/filings/0001280784-26-000027.md) | [(145) d](/filings/0001280784-26-000042.md) | [(3.2) d](/filings/0001280784-26-000054.md) | [(55.6) d](/filings/0001280784-26-000009.md) | [(231)](/filings/0001280784-26-000027.md) | [298 d](/filings/0001280784-26-000042.md) | [(166) d](/filings/0001280784-26-000054.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.49](/filings/0001280784-24-000007.md) | [0.79](/filings/0001280784-25-000007.md) | [2.31](/filings/0001280784-26-000009.md) | [1.61](/filings/0001280784-26-000009.md) | [1.85](/filings/0001280784-26-000009.md) |
| Free cash flow | $m | [129](/filings/0001280784-24-000007.md) | [(425)](/filings/0001280784-25-000007.md) | [67.4](/filings/0001280784-26-000009.md) | [(119)](/filings/0001280784-26-000009.md) | [(426)](/filings/0001280784-26-000009.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/htgc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $61.2m | 3,877,634 |  | Added +713,653 |
| [Sound Income Strategies, LLC](/funds/1730960.md) | 2026-06-30 | $57.8m | 3,667,518 |  | Added +285,460 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $46.3m | 2,937,122 |  | Added +2,121,737 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $41.7m | 2,645,744 |  | Added +151,752 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $35.7m | 2,265,824 |  | Reduced −59,035 |
| [LPL Financial LLC](/funds/1403438.md) | 2026-06-30 | $29.3m | 1,857,272 |  | Added +61,595 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $28.6m | 1,812,484 |  | Added +547,868 |
| [Legal & General Group Plc](/funds/764068.md) | 2026-06-30 | $26.5m | 1,681,333 |  | Added +182,680 |
| [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $21.8m | 1,383,905 |  | Added +248,416 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $21.7m | 1,373,460 |  | Reduced −175,500 |

## Recent filings

[All 2,263 filings](/companies/htgc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:29 ET | [8-K](/filings/0001280784-26-000055.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001280784-26-000055 |
| 2026-10-29 | 16:16 ET | [10-Q](/filings/0001280784-26-000054.md) | Quarterly report, period 2026-09-30 | 0001280784-26-000054 |
| 2026-10-08 | 16:19 ET | [8-K](/filings/0001628280-26-065459.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-065459 |
| 2026-09-17 | 16:16 ET | [8-K](/filings/0001280784-26-000046.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001280784-26-000046 |
| 2026-07-30 | 16:30 ET | [8-K](/filings/0001280784-26-000043.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001280784-26-000043 |
| 2026-07-30 | 16:17 ET | [10-Q](/filings/0001280784-26-000042.md) | Quarterly report, period 2026-06-30 | 0001280784-26-000042 |
| 2026-07-24 | 16:16 ET | [8-K](/filings/0001280784-26-000035.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001280784-26-000035 |
| 2026-07-21 | 08:44 ET | [8-K](/filings/0001280784-26-000032.md) | 2.02 Results of operations; 8.01 Other events | 0001280784-26-000032 |
| 2026-06-18 | 16:30 ET | [8-K](/filings/0001280784-26-000030.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001280784-26-000030 |
| 2026-05-05 | 16:30 ET | [8-K](/filings/0001280784-26-000028.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001280784-26-000028 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001280784-26-000009.md), filed Feb 12, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1280784
- Tickers: HTGC, HCXY
- Exchange: NYSE
- SIC code: not reported
- State of incorporation: MD
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 18:11 ET. No prices; not investment advice.